Recruiting
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.
ClinicalTrials.gov IDNCT07231159
PhaseNot Applicable
Enrollment200
SponsorAdventHealth
Age18 Years
SexALL
Conditions studied
Breast Cancer, Lung Cancer (Diagnosis), Prostate Cancer
About this study
To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.
Interventions
- Behavioral: referral for definitive diagnosis based on their cancer screening results — Need for radiological diagnosis
- Behavioral: Engagement — Engage in stakeholder focus groups to provide feedback about program operations
Primary outcomes
- The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance, (From enrollment to the end of the 3 month follow-up for a total of 12 months)
Eligibility information
Inclusion Criteria:
1. Adult aged 18 or older
2. Seeking care at a CRS or emergency department
3. Meets criteria for lung, breast, and/or prostate cancer screening, as outlined below:
1. Lung cancer: Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years
2. Breast cancer: Women aged 40 to 74 years
3. Prostate cancer: Men aged 55 to 69 years
4. Receives a positive screening result for lung, breast, and/or prostate cancer at a study site
Exclusion Criteria:
1. Displays behavior disruptive to other patients or staff
2. Refusal to accept screening for breast, lung, and/or prostate cancers
Study locations
- Adventhealth, Orlando, Florida 32804 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.